Abstract
Cyclobenzaprine has been cited as a co-factor or cause in serotonin syndrome following co-ingestion of other psychotropic medications. An observational study was conducted for a cumulative consumption of this agent among patients for 24 years, 8 months; no evidence of serotonin syndrome or malignant neuroleptic disorder was apparent despite a variety of concomitant psychotropic medications used. doi:10.4021/jmc241w
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
